Related Experiment Video
Updated: Dec 5, 2025

Characterization of Molecular Mechanisms of In vivo UVR Induced Cataract
Published on: November 28, 2012
Pharmacological inhibition of Kv3 on oxidative stress-induced cataract progression
Min Seok Song1, Hun Ju Sim1, Seonmi Kang2
1Laboratory of Veterinary Pharmacology, College of Veterinary Medicine, Republic of Korea.
Abstract:
Oxidative stress is one of the most important risk factors for cataractogenesis. Previous studies have indicated that BDS-II, a Kv3 channel blocker, plays pivotal roles in oxidative stress-related diseases. This study demonstrates that BDS-II exerts a protective effect on cataractogenesis. Specifically, BDS-II was observed to inhibit lens opacity induced by H2O2. BDS-II was also determined to inhibit cataract progression in a sodium selenite-induced in vivo cataract model by inhibiting reduction of the total GSH. In addition, BDS-II was demonstrated to protect human lens epithelial cells against H2O2-induced cell death. Our results suggest that BDS-II is a potential pharmacological candidate in cataract therapy.
Insights
BDS-II, a Kv3 channel blocker, shows promise in preventing and treating cataracts. This compound protects against oxidative stress-induced lens opacity and cell death, suggesting its potential as a therapeutic agent for cataractogenesis.
Area of Science:
- Ophthalmology
- Cell Biology
- Pharmacology
Background:
- Oxidative stress is a primary risk factor for cataractogenesis.
- Kv3 channel blockers, like BDS-II, are implicated in oxidative stress-related diseases.
Purpose of the Study:
- To investigate the protective effects of BDS-II against cataractogenesis.
- To evaluate BDS-II's efficacy in both in vitro and in vivo cataract models.
Main Methods:
- Assessing BDS-II's inhibition of H2O2-induced lens opacity.
- Evaluating BDS-II's effect on glutathione (GSH) levels in a sodium selenite-induced in vivo cataract model.
- Testing BDS-II's protective capacity against H2O2-induced cell death in human lens epithelial cells.
Main Results:
- BDS-II significantly inhibited H2O2-induced lens opacity.
- BDS-II treatment prevented the reduction of total GSH in an in vivo cataract model.
- BDS-II demonstrated cytoprotective effects on human lens epithelial cells against oxidative stress.
Conclusions:
- BDS-II exhibits significant protective effects against cataractogenesis.
- BDS-II's mechanism involves mitigating oxidative stress and preserving glutathione levels.
- BDS-II represents a potential pharmacological candidate for cataract therapy.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Oxidation of Phenols to Quinones
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...

